UBX

Unity Btech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.540
+0.090
+2.61%
After Hours: 3.550 +0.01 +0.28% 19:58 09/25 EDT
OPEN
3.440
PREV CLOSE
3.450
HIGH
3.580
LOW
3.340
VOLUME
446.99K
TURNOVER
--
52 WEEK HIGH
15.44
52 WEEK LOW
2.720
MARKET CAP
184.22M
P/E (TTM)
-1.9067
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Silicon Valley's most prominent VC firm had a banner week: $9 billion in IPO shares while helping TikTok negotiations
Venture capital firm Sequoia has long been the envy of its Silicon Valley peers, but has rarely had a week like this one.
CNBC.com · 09/18 21:22
UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology
\- Corporate restructuring to extend cash runway through mid-2022 and key milestones -\- UBX1325 to enter clinical development in patients with diabetic macular edema -SAN FRANCISCO, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company
GlobeNewswire · 09/15 12:00
Unity is seizing control of IPO pricing from bankers, a rare move that could limit first-day pop
As Unity prepares for its stock market debut this week, CEO John Riccitiello will be making the decision on where the shares price, taking control from bankers
CNBC.com · 09/14 20:23
UNITY Biotechnology to Participate in Upcoming September Investor Conferences
SAN FRANCISCO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate in the following
GlobeNewswire · 09/04 13:00
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31)
Benzinga · 09/01 12:35
New finance chief for Unity Biotechnology
Unity Biotechnology (UBX) has appointed Lynne Sullivan as chief financial officer, effective September 1, 2020. Ms. Sullivan most recently served as CFO for Compass Therapeutics.Shares up 1.3% premarket.Press release
Seekingalpha · 09/01 11:24
UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial Officer
SAN FRANCISCO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced the appointment of Lynne Sullivan to the permanent role of chief financial
GlobeNewswire · 08/31 21:05
Unity Biotechnology (UBX) Jumps: Stock Rises 7.1%
Unity Biotechnology (UBX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Zacks · 08/25 13:39
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of UBX. Analyze the recent business situations of Unity Btech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average UBX stock price target is 5.67 with a high estimate of 12.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 110
Institutional Holdings: 25.08M
% Owned: 48.20%
Shares Outstanding: 52.04M
TypeInstitutionsShares
Increased
30
2.73M
New
33
500.32K
Decreased
13
202.49K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.04%
Pharmaceuticals & Medical Research
+1.58%
Key Executives
Chairman/Director
Keith Leonard
President/Co-Founder/Director
Nathaniel David
Chief Executive Officer/Director
Anirvan Ghosh
Chief Financial Officer
Lynne Sullivan
Chief Accounting Officer/Vice President - Finance
Alexander Azoy
Chief Scientific Officer
Dan Marquess
General Counsel/Secretary
Tamara Tompkins
Executive Officer
Jamie Dananberg
Director
Mary Campbell
Director
Robert Nelsen
Director
Luis Visoso
Independent Director
Paul Berns
Independent Director
Kristina Burow
Independent Director
Graham Cooper
Independent Director
David Lacey
Independent Director
Margo Roberts
Independent Director
Camille Samuels
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About UBX
Unity Biotechnology, Inc. is a clinical stage biotechnology company engaged in developing therapeutics to treat ageing related diseases. The Company develops therapeutics for age-associated diseases such as arthritis, vision loss, and cognitive decline. It develops a range of Senolytic medicines that eliminate senescent cells and stop the production of Senescence Associated Secretory Phenotype. Its pipelines of products that target cellular senescence are in its clinical development stage. Its lead products candidates include senolytic molecules, UBX0101 and UBX1967, designed for local treatment for the removal of accumulated senescent cells.UBX0101 is a drug candidate developed for musculoskeletal diseases targeting osteoarthritis. It is a inhibitor of the MDM2/p53 protein interaction that eliminates senescent cells. UBX1967 is targeted at ophthalmologic diseases. It is a senolytic small molecule inhibitor of specific members of the Bcl-2 family of apoptosis regulatory proteins.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Unity Biotechnology Inc stock information, including NASDAQ:UBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UBX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading UBX stock methods without spending real money on the virtual paper trading platform.